Newstral
Joel Beatty
- BAnalysts Are Downgrading Intercept Pharmaceuticals. Here’s Why.barrons.com
- BBuy Amarin Because It Is Cheap, Analyst Saysbarrons.com
- BIntercept Pharma Has a New Liver Drug. Don’t Expect FDA Approval to Lift the Stock, Analyst Says.barrons.com
- BAmarin Stock Has Soared. Why Citi Thinks It’s Gone Far Enough.barrons.com
- B2 Small Biotech Stocks Make Citi’s Top 5 Listbarrons.com
- BSolid Biosciences Falls as Analyst Says Nothing Fundamental Has Changedbarrons.com
Frequent names
Newstral's extraction of names of people and organisations from the world's news is completely automated. If you do not want your name to appear here, please contact us. We will be happy to look at your request.